Clinical Analysis of Laparoscopic Hysterectomy in the Treatment of Adenomyosis

Objective To evaluate the clinic effects of laparoscopic subtotal hysterectomy(LSH) and laparoscopic total hysterectomy(LTH) in treating adenomyosis.Methods From January 2010 to September 2011,a total of 200 cases with adenomyosis were included into this study.They were divided into two groups according to different operation methods,LSH group(n=100) and LTH group(n=100).There had no significant difference on age and complications between two groups(P0.05).The study protocol was approved by the Ethical Review Board of Investigation in Human Being of West China Second University Hospital.Informed consent was obtained from all participates.The following items were observed retrospectively,surgical indicators(operation duration,blood loss and postoperative blood transfusion situation),indicators of short-term recovery(postoperative indwelling catheter time,placement of negative pressure drainage,anal exhaust time,postoperative pain score,and hospital stay),and indicators of long-term follow-up(alleviation situation of postoperative dysmenorrheal,assessment of sexual life quality,quality evaluation of daily life,pelvic floor tissue support,lesions and malignant transformation rate of cervical stump,as well as the existence of persistent postoperative cyclical vaginal bleeding).Results The operation duration,blood loss of LSH group were less than those in LTH group,with significant difference(P0.05),the duration of urethral catheterizationn and hospital stay in LSH group were significantly shorter than those of LTH group,with significant difference(P0.05);but there were no statistic significant difference between two groups among anal exhaust time,postoperative pain score,assessment of sexual life quality,quality evaluation of daily life(P0.001).Dysmenorrhea symptoms of two groups were remission,and the incidence of postoperative complications were lower.Conclusions The clinical effects of LSH group is better than that of LTH group,and LSH is recommended in treating adenomyosis.